Research Study Name

Consultants in Cardiology PC


 

TherOx

 

 

Comparison of new stents for equivalency of reduction in vascular events (CONSERVE)

 

 

The open evaluation comparing stent thrombosis rate of the BX Velocity Heparin coated stent and the BX Velocity Stent

 

 

TherOx Aqueous Oxygen System -Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT) Phase II Clinical Trial

 

 

The occluded artery trial (OAT)

 

 

CAPTIVE:  CardioShield application protects during transluminal intervention of vein graft by reducing emboli

 

 

Addressing the value of primary angioplasty after combination therapy or eptifibatide monotherapy in acute myocardial infarction (The ADVANCE MI Study)

 


 

Enlighten II Clinical Trial:  A Non-randomized Evaluation fo the 3.5mm and 4.0 Multi-Link Vision RX Coronary System in the Treatment of Patients with DeNovoNative Coronary Artery Lesions

 

 

Protocol H7T-MC-TAAH:  Double-blind, randomized, multicenter, dose-ranging trial of CS-747 compared with clopidogrel in subjects undergoing percutaneous coronary intervention

 

 

Proximal protection during saphenous vein graft intervention using the Proxis TM embolic protection system:  A randomized, two-arm, controlled trial:  The Proximal Trial

 

 

STEEPLE - Safety and efficacy of enoxaparin in PCI patients, an international, randomized evaluation.  Aventis protocol XRP4563/4001

 

 

THE ACUITY TRIAL:  A randomized comparison of Angiomax (bivalirudin) versus Lovenox/Clexane (enoxaparin) in paitents undergoing early invasive management for acute coronary syndromes without ST-segment elevation

 

 

Time to Integrelin Therapy in Acute Myocardial Infarction TITAN - TIMI 34

 

 

Protocol HIC-99-225:  A prospective randomized trial of primary angioplasty versus thrombolytic therapy for acute myocardial infarction in the elderly.  The Senior PAMI Trial

 

 

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF)

 

 

Early ACS

 

 

EVENT REGISTRY:  A Multicenter Registry for the Evaluation of Drug Eluting Stents and Ischemic Events

 

RESTORE US Study

 

IMPROVE HF Study